Identification of Maltase Glucoamylase as a Biomarker of Acute Kidney Injury in Patients with Cirrhosis

<div>(a, b) Immunoblotting of cirrhosis-AKI urine exosomes for maltase-glucoamylase (MGAM). (a) Tamms–Horsfall protein blot for exosome loading control. (b) MGAM protein blot. Lanes 1 and 6: blank, lanes 2 and 3: normal control (noncirrhotic) urine exosome protein, and lanes 4 and 5: cirrhotic subjects with ascites and kidney injury.</div>

Critical Care Research and Practice

fig4

Figure 4

Figure 4: Identification of Maltase Glucoamylase as a Biomarker of Acute Kidney Injury in Patients with Cirrhosis 